Journal of Hematological Malignancies

>> The journal is under re-structure, and will not accept new submissions. Thanks. 

Journal of Hematological Malignancies (ISSN 1925-4024, EISSN 1925-4032) is an open access international scientific journal providing a forum for peer-reviewed articles, reviews or commentary related to all aspects of the prevention, diagnosis and management of malignancies of the blood system, as well as related molecular and cell biology, genetics, pathophysiology, epidemiology, and randomized controlled trials and evidence-based meta-analysis or pooled analysis related to specific trials.

JHM is included in:

  • EBSCOhost
  • Gale's Academic Databases
  • Google Scholar
  • Lockss
  • PKP Open Archives Harvester
  • ProQuest
  • The Standard Periodical Directory

To facilitate rapid publication and minimize administrative costs, JHM accepts submissions online or by e-mail ( For online submission, please register and then follow the instructions given.

JHM’s Section:
Original Research, Case Report, Conference Report, Reviews.



What is e-Version FirstTM

e-Version First is a feature offered through our journal platform. It allows PDF version of manuscripts that have been peer reviewed and accepted, to be hosted online prior to their inclusion in a final printed journal. Readers can freely access or cite the article. We aim to publish accepted manuscripts in e-Version First in two week's time after the final draft completed.


Paper Selection and Publishing Process

a) Submission Acknowledgement

When you submit a manuscript online, you will receive a submission acknowledgement letter sent by the online system automatically. For email submission, the editor or editorial assistant sends an e-mail confirmation to the submission’s author within one to three working days. If you fail to receive this confirmation, please check your bulk email box or contact the editorial assistant by email:

b) Basic Review

The editor or editorial assistant determines whether the manuscript fits the journal’s focus and scope. Next a check for the similarity rate is done using CrossCheck, powered by iThenticate. Any manuscripts out of the journal’s scope or containing plagiarism, including self-plagiarism, are rejected.

c) Peer Review

We use a double-blind system for peer review; both reviewers’ and authors’ identities remain anonymous. The submitted manuscript will be reviewed by at least two experts: one editorial staff member as well as one to three external reviewers. The review process may take two to four weeks.

d) Decision Is Made

The decision to accept or reject an article is based on the suggestions of reviewers. If differences of opinion occur between reviewers, the editor-in-chief will weigh all comments and arrive at a balanced decision based on all comments, or a second round of peer review may be initiated.

e) Notification of the Result of Review

The result of review will be sent to the corresponding author and forwarded to other authors.

f) Publication Fee Is Paid

If the submission is accepted, the authors revise paper and pay the publication fee (300.00USD).

g) Publication Notice

The authors and readers will be notified and invited to visit our website for the newly published articles.




Call for Papers-Journal of Hematological Malignancies


We are seeking submissions for forthcoming issue published in September 2018. The paper should be written in professional English. The length of 3000-8000 words is preferred. All manuscripts should be prepared in MS-Word format, and submitted online: or sent to:

For any further information about the journal, please log on its website:

It is also appreciated if you could share this information with your colleagues and associates. Thank you.

Posted: 2017-10-20 More...

Journal of Hematological Malignancies(JHM)formed Editorial Review Board

JHM'S Editorial Review Board has been established, consisting of more than 80 surgeons, radiologists, researchers and experts in blood-related conditions, as well as the treatment of hematological malignancies area.  
Posted: 2011-09-02 More...
More Announcements...

Vol 4, No 1 (2018)

Journal of Hematological Malignancies, Vol. 4, No. 1, 2018, e-Version FirstTM

Table of Contents

Case Reports

Yvonne Chu, Umit Tapan, Adam Lerner